Help Improve HEDIS, STAR Ratings and HCC Risk Factors by Closing Care Gaps

Intercepting patients during routine primary care office visits with a teleretinal program like the RetinaVue care delivery model can help providers achieve up to 90% documented compliance with diabetic retinal exams in just 12 months.1

That means potential financial incentives from quality programs — and more importantly, the opportunity to help save more patients’ vision. Learn more in our eBook, The Solution is in Sight, The Complete Guide to a Successful Teleretinal Program.

90%

Documented compliance with diabetic retinal exams in just 12 months.1

Welch Allyn® RetinaVue® 700 Imager
Woman Checking RetinaVue700

Help Save Vision for Patients Living with Diabetes in Primary Care

Diabetic Retinopathy is the leading cause of blindness in working-age adults.

95%

95% of vision loss due to diabetic retinopathy can be prevented with early detection.

RetinaVue Care Delivery Model

Help preserve the vision of your patients living with diabetes with a simple eye exam that takes minutes to complete for diabetic retinopathy detection during routine primary care visits. Baxter delivers the three keys to a successful teleretinal program:

Simple and Affordable Hardware

Simple and Affordable Hardware

Secure Software Network

Secure Software Network

Nationwide Services and Support

Nationwide Services and Support

EMR Connected Workflow

Order exams in your EMR

ORDER

Exams in your EMR

 

Aquire images with Simple and Affordable Retinal Cameras

ACQUIRE

Images with Simple and Affordable Retinal Cameras

Transfer images Securely with HIPAA - compliant SOC-2 Certified Software

TRANSFER

Images Securely with HIPAA - compliant SOC-2 and HITRUST R2 Certified Software

 

Results from Remote Opthalmologists Returned in One Business Day

RESULTS

Diabetic Retinopathy Evaluation from Remote Ophthalmologists Returned in One Business Day

 


See the RetinaVue 700 Imager in Action

The most advanced handheld retinal camera* in patient-centered retinal imaging technology made for primary care.

  

Welch Allyn® RetinaVue® 700 Imager play_circle_outline

Welch Allyn® RetinaVue® 700 Imager

RetinaVue 700 Imager >

50%
60% of diabetic patients or less comply with annual retinal exams2
80%
80% of patients will eventually develop some stage of diabetic retinopathy3
90%
Achieve up to 90% diabetic retinal exam compliance in 12 months1

Help Improve Outcomes

  • Accurately document chronic conditions such as diabetes and its complications to help inform care planning, appropriate coverage and quality performance

  • Improve total cost of care with early detection and treatment
Beautiful young woman looking at camera

 

…By allowing this test to be covered in my office and other primary care settings, we are making access to recommended annual diabetic eye exams more convenient for patients and thereby saving patients’ vision.


Not only is this technology unquestionably effective, it is relatively straightforward to incorporate into the regular diabetic office visit and presents an ideal opportunity to discuss eye health with the patient. We have expanded the program from one clinic to all four of our clinics in the last few months.”

-Dr, Robert Berke, Chautauqua Family Health Services

Welch Allyn® RetinaVue® 700 Imager play_circle_outline

Before it's too late

Watch Monica’s story of losing her vision after diabetic retinopathy was detected too late.


See the Proof

Case Studies and White Papers

  

Request a Virtual Demo

Request a demo of the RetinaVue care delivery model by completing the form.

Welch Allyn® RetinaVue® 700 Imager

*Comparison of specifications of commercially available handheld retinal cameras for the primary care market in the US as of September 17, 2024.

Rx Only: For safe and proper use of the products mentioned herein, please refer to the appropriate Operator’s Manual or Instructions for Use.

References:

1 Mansberger SL, Gleitsmann K, Gardiner S, et al. Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Telemed J E Health. 2013 Dec; 19(12): 942-8.

2 Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/1

3 Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.doi.org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/19

Baxter, Hillrom, RetinaVue and Welch Allyn are trademarks of Baxter International Inc. or its subsidiaries.
Any other trademarks, product names or brand images appearing herein are the property of their respective owners.
US-FLC147-240136 (v1.0) 10/2024